Elizabeth Anne Gasser net worth and biography

Elizabeth Gasser Biography and Net Worth

Elizabeth A. Gasser serves as Executive Vice President - Strategy and Corporate Development of the Company. She has served as our Executive Vice President of Strategy and Corporate Development since January 2020. Prior to joining us, Ms. Gasser served from June 2017 as an independent adviser providing strategic and corporate development solutions to boards and executive teams. From January 2016 to June 2017 she was Vice President of Corporate Strategy at QUALCOMM Technologies, Inc. (QTI), a subsidiary of QUALCOMM Incorporated (NASDAQ: QCOM), a global leader in the development and commercialization of technologies and products used in mobile devices and other wireless products. Prior to that, from November 2012 to January 2016 she was Vice President of Strategic Development at QTI, after serving in other strategic related roles of increasing responsibility beginning in 2006. Ms. Gasser holds a B.A. and an M.A. in Economics from the University of Cambridge.

How old is Elizabeth Anne Gasser?: Ms. Gasser is currently 48 years old. There are 8 older executives and no younger executives at Tandem Diabetes Care. The oldest executive at Tandem Diabetes Care is Mr. John F. Sheridan, President, CEO & Director, who is 69 years old. Learn More on Elizabeth Anne Gasser's age.
How do I contact Elizabeth Anne Gasser?: The corporate mailing address for Ms. Gasser and other Tandem Diabetes Care executives is 11075 ROSELLE STREET, San Diego CA, 92121. Tandem Diabetes Care can also be reached via phone at (858) 366-6900 and via email at [email protected]. Learn More on Elizabeth Anne Gasser's contact information.
Has Elizabeth Anne Gasser been buying or selling shares of Tandem Diabetes Care?: Elizabeth Anne Gasser has not been actively trading shares of Tandem Diabetes Care within the last three months. Most recently, Elizabeth Anne Gasser sold 1,084 shares of the business's stock in a transaction on Monday, December 27th. The shares were sold at an average price of $151.36, for a transaction totalling $164,074.24. Learn More on Elizabeth Anne Gasser's trading history.
Who are Tandem Diabetes Care's active insiders?: Tandem Diabetes Care's insider roster includes David Berger (EVP), Kim Blickenstaff (Director), Elizabeth Gasser (EVP), Brian Hansen (EVP), James Leal (SVP), Kathleen McGroddy-Goetz (Director), Susan Morrison (EVP), Rebecca Robertson (Director), John Sheridan (CEO), Christopher Twomey (Director), and Leigh Vosseller (CFO). Learn More on Tandem Diabetes Care's active insiders.
Are insiders buying or selling shares of Tandem Diabetes Care?: In the last twelve months, Tandem Diabetes Care insiders bought shares 1 times. They purchased a total of 532 shares worth more than $12,363.68. In the last twelve months, insiders at the medical device company sold shares 3 times. They sold a total of 25,000 shares worth more than $858,400.00. The most recent insider tranaction occured on November, 20th when Director Kim D Blickenstaff sold 10,000 shares worth more than $300,000.00. Insiders at Tandem Diabetes Care own 2.2% of the company. Learn More about insider trades at Tandem Diabetes Care.
Information on this page was last updated on 11/20/2024.

Elizabeth Anne Gasser Insider Trading History at Tandem Diabetes Care

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
12/27/2021	Sell	1,084	$151.36	$164,074.24
12/7/2021	Sell	1,083	$140.00	$151,620.00

Elizabeth Anne Gasser Buying and Selling Activity at Tandem Diabetes Care

Tandem Diabetes Care Company Overview

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Today's Range

Now: $35.91

$32.46

$36.31

50 Day Range

MA: $32.34

$27.34

$37.61

2 Week Range

Now: $35.91

$21.85

$53.69

Volume

4,334,886 shs

Average Volume

1,585,730 shs

Market Capitalization

$2.36 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.32

Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong

From Brownstone Research | Ad

Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.

Click here to watch this demo and decide for yourself.